152 related articles for article (PubMed ID: 6943371)
21. Role of natural killer cells in cancer.
Pross HF; Lotzová E
Nat Immun; 1993; 12(4-5):279-92. PubMed ID: 8257832
[TBL] [Abstract][Full Text] [Related]
22. [The comparison of biological characteristics between tumor-infiltrating lymphocytes and tumor-associated lymphocytes in ascites of epithelial ovarian carcinoma].
Kang S; Shen K; Lang J
Zhonghua Fu Chan Ke Za Zhi; 1998 Oct; 33(10):607-10. PubMed ID: 10806687
[TBL] [Abstract][Full Text] [Related]
23. Significant differences of lymphocytes isolated from ascites of patients with ovarian cancer compared to blood and tumor lymphocytes. Association of CD3+CD56+ cells with platinum resistance.
Bamias A; Tsiatas ML; Kafantari E; Liakou C; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Tsitsilonis O; Bamia C; Papatheodoridis G; Politi E; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2007 Jul; 106(1):75-81. PubMed ID: 17433425
[TBL] [Abstract][Full Text] [Related]
24. The lack of NK cytotoxicity associated with fresh HUCB may be due to the presence of soluble HLA in the serum.
Webb BJ; Bochan MR; Montel A; Padilla LM; Brahmi Z
Cell Immunol; 1994 Dec; 159(2):246-61. PubMed ID: 7994757
[TBL] [Abstract][Full Text] [Related]
25. 2',5'-Oligoadenylate trimer core and the cordycepin analog augment the tumoricidal activity of human natural killer cells.
Black PL; Henderson EE; Pfleiderer W; Charubala R; Suhadolnik RJ
J Immunol; 1984 Nov; 133(5):2773-7. PubMed ID: 6332860
[TBL] [Abstract][Full Text] [Related]
26. Suppression of natural killer cell activity in biliary obstruction.
Lane DR; Joshi P; Grogan JB; Nie CH; Scott-Conner CE
Am Surg; 1996 Apr; 62(4):259-62. PubMed ID: 8600843
[TBL] [Abstract][Full Text] [Related]
27. Human natural killer cells: a comprehensive review.
Sinkovics JG; Horvath JC
Int J Oncol; 2005 Jul; 27(1):5-47. PubMed ID: 15942642
[TBL] [Abstract][Full Text] [Related]
28. Contrasting effects of lactoferrin on human lymphocyte and monocyte natural killer activity and antibody-dependent cell-mediated cytotoxicity.
Nishiya K; Horwitz DA
J Immunol; 1982 Dec; 129(6):2519-23. PubMed ID: 7142699
[TBL] [Abstract][Full Text] [Related]
29. Suppression of human natural and antibody-dependent cytotoxicity by soluble factors from unstimulated normal lymphocytes.
Nair MP; Schwartz SA
J Immunol; 1982 Dec; 129(6):2511-8. PubMed ID: 6183335
[TBL] [Abstract][Full Text] [Related]
30. Natural killer cell activity depression in peripheral blood and ascites from gastric cancer patients with high TGF-beta 1 expression.
Yoon SJ; Heo DS; Kang SH; Lee KH; Kim WS; Kim GP; Lee JA; Lee KS; Bang YJ; Kim NK
Anticancer Res; 1998; 18(3A):1591-6. PubMed ID: 9673375
[TBL] [Abstract][Full Text] [Related]
31. Low natural killer cell activity in the bone marrow of healthy donors with normal killer cell activity in the peripheral blood.
Talpaz M; Spitzer G
Exp Hematol; 1984 Sep; 12(8):629-32. PubMed ID: 6489474
[TBL] [Abstract][Full Text] [Related]
32. Natural killer (NK) cell activity in the rat. I. Isolation and characterization of the effector cells.
Reynolds CW; Timonen T; Herberman RB
J Immunol; 1981 Jul; 127(1):282-7. PubMed ID: 7240744
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of human natural killer activity by 2-deoxy-D-glucose and other sugars.
Schlesinger M; Bekesi JG
J Clin Lab Immunol; 1984 Sep; 15(1):19-26. PubMed ID: 6512844
[TBL] [Abstract][Full Text] [Related]
34. Characterization of the lysis of fresh human solid tumors by autologous lymphocytes activated in vitro with phytohemagglutinin.
Mazumder A; Grimm EA; Rosenberg SA
J Immunol; 1983 Feb; 130(2):958-64. PubMed ID: 6848602
[TBL] [Abstract][Full Text] [Related]
35. Regulation of natural killer function by nonlymphoid cells.
Shau H; Roth MD; Golub SH
Nat Immun; 1993; 12(4-5):235-49. PubMed ID: 8257829
[TBL] [Abstract][Full Text] [Related]
36. Lymphocytes infiltrating ovarian carcinoma: modulation of functional activity by intraperitoneal treatment with biological response modifiers.
Allavena P; Peri G; Di Bello M; Peccatori F; Chiaffarino F; Pirovano P; Mantovani A
Nat Immun Cell Growth Regul; 1988; 7(4):230-8. PubMed ID: 3070372
[TBL] [Abstract][Full Text] [Related]
37. Deficient natural killer cell activity in alcoholic cirrhosis.
Charpentier B; Franco D; Paci L; Charra M; Martin B; Vuitton D; Fries D
Clin Exp Immunol; 1984 Oct; 58(1):107-15. PubMed ID: 6236915
[TBL] [Abstract][Full Text] [Related]
38. Correlation of NK T-like CD3+CD56+ cells and CD4+CD25+(hi) regulatory T cells with VEGF and TNFalpha in ascites from advanced ovarian cancer: Association with platinum resistance and prognosis in patients receiving first-line, platinum-based chemotherapy.
Bamias A; Koutsoukou V; Terpos E; Tsiatas ML; Liakos C; Tsitsilonis O; Rodolakis A; Voulgaris Z; Vlahos G; Papageorgiou T; Papatheodoridis G; Archimandritis A; Antsaklis A; Dimopoulos MA
Gynecol Oncol; 2008 Feb; 108(2):421-7. PubMed ID: 18036640
[TBL] [Abstract][Full Text] [Related]
39. Countercurrent distribution of human peripheral blood lymphocytes: isolation of a subpopulation enriched with natural killer and K cells.
Levy EM; Zanki S; Walter H
Eur J Immunol; 1981 Nov; 11(11):952-5. PubMed ID: 7327197
[TBL] [Abstract][Full Text] [Related]
40. [The effect of serum on NK cell activity].
Konjević G; Spuzić I
Glas Srp Akad Nauka Med; 1991; (41):113-20. PubMed ID: 1916438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]